Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels is a research paper published in Proceedings of the National Academy of Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 61 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Gouvernement du Canada | Canadian Institutes of Health Research
Grant: MOP- 142425
Canadian Cancer Society
Grant: CCS #: 706878
HHS | National Institutes of Health
Grant: NIH-NCI R01 CA212376
NIAID NIH HHS
Grant: R01 AI089824
CIHR
Grant: FDN-143281
NCI NIH HHS
Grant: R01 CA212376
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01CA212376-04
An innate immune checkpoint in cancer immunotherapy
FWCI
3.52
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals